The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
|Articles|March 15, 2015
- Pharmaceutical Technology-03-15-2015
- Volume 2015 eBook
- Issue 1
Innovations in Solid Dosage Equipment
Author(s)Ashley Roberts
New technologies for solid dosage manufacturing are examined.
Advertisement
The increasing complexity of manufacturing pharmaceuticals has necessitated more complex manufacturing options and has been the driving force behind the equipment, including high-, medium-, and small-volume tablet presses.
Download
.
Articles in this issue
over 11 years ago
Advances in Tabletingover 11 years ago
Assessing and Improving the Palatability of Pharmaceuticalsover 11 years ago
Analytical Techniques for Oral Solid Dosage Formulationover 11 years ago
Simplify Formulation With PATover 11 years ago
Boosting Solubility in Lipid-Based FormulationsAdvertisement
Related to this article
The agency issued a direct final rule that supports the use of innovative testing methods to limit the use of animals and maintain existing safety standards.
The FDA approves Inluriyo-Verzenio combo for ESR1-mutated breast cancer; EMBER-3 data double PFS, with supply chain and diagnostics implications for manufacturers.
The Leadership Summit will bring senior pharma executives together to discuss supply chain resilience, medicine security, and manufacturing capacity amid growing geopolitical fragmentation.
This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Weekly Basal Insulin Efsitora: A New Biologics CMC Benchmark
2
EU Clears AstraZeneca's Trixeo for Asthma, Opening New Manufacturing Demand for Single-Inhaler Triple Therapy
3
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
4
Ask the Expert: Post-Approval Changes
5